|
|
|
40
|
4181W
|
OCREVUS 300MG INJ (ROC/AHI) OCRELIZUMAB
|
OCRELIZUMAB
|
OCREVUS
|
10ML
|
C
|
17,533.1
|
17,533.1
|
INJECTION
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181W
|
OCREVUS 300MG INJ (ROC) OCRELIZUMAB (BQ)
|
OCRELIZUMAB
|
OCREVUS
|
10ML
|
BQ
|
17533.19
|
17533.189
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
42
|
4181W
|
OCREVUS 300MG INJ (ROC) OCRELIZUMAB
|
OCRELIZUMAB
|
OCREVUS
|
10ML
|
BQ
|
15,779.87
|
15,779.87
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2026-04-01
|
|
|
IV
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|